Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Histidine Tag (His-Tag) Antibody Market Set To Climb From $1.6 Billion In 2026 To $2.48 Billion By 2030
The histidine tag (his-tag) antibody market size has seen rapid growth recently. It is projected to expand from $1.43 billion in 2025 to $1.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.8%. This historical growth can be attributed to several factors, including the increase in recombinant protein research, the expansion of academic life science laboratories, the rising adoption of affinity purification techniques, the widespread availability of standardized tagging methods, and augmented funding for molecular biology research.
The histidine tag (his-tag) antibody market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. This growth during the forecast period is primarily driven by an increasing need for sophisticated protein analysis instruments, the expanding scope of biopharmaceutical research pipelines, the rising acceptance of recombinant and nanobody formats, a heightened emphasis on assay sensitivity and accuracy, and greater automation within laboratory workflows. Key trends anticipated for the forecast period encompass a surging demand for highly specific research antibodies, the increasing application of his-tag antibodies for protein purification, the wider adoption of recombinant antibody formats, an expansion in studies involving tagged protein expression, and an intensified focus on reproducibility in life science research.
Get A Free Sample Report With In-Depth Market Insights:
Histidine Tag (His-Tag) Antibody Market Growth Drivers: What’s Behind The Acceleration?
The increasing demand for biopharmaceuticals is anticipated to drive the expansion of the histidine tag (His-Tag) antibody market in the coming years. Biopharmaceuticals are therapeutic products created using biological sources or biotechnology methods, as opposed to conventional chemical synthesis. This growing need for biopharmaceuticals is a result of the rising prevalence of chronic and complex diseases, which necessitates advanced targeted therapies that traditional medications cannot effectively address. Histidine tag (His-Tag) antibodies support biopharmaceutical research by enabling the precise detection and purification of recombinant proteins, making them crucial for drug development and the production of therapeutic proteins. They reduce experimental errors by offering high specificity and reproducibility, thereby enhancing research efficiency and bioprocess reliability. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, prescription drug outlays increased by 11.4% in 2023, reaching $449.7 billion, an acceleration from the 7.8% growth observed in 2022. Thus, the escalating demand for biopharmaceuticals is fueling the growth of the histidine tag (His-Tag) antibody market.
Histidine Tag (His-Tag) Antibody Market Segment Analysis Spotlighting Growth Areas
The histidine tag (his-tag) antibody market covered in this report is segmented –
1) By Product Type: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Nanobodies, Other Product Types
2) By Application: Western Blotting, Immunoprecipitation, Flow Cytometry, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs), Other End-Users
Subsegments:
1) By Monoclonal Antibodies: Mouse Monoclonal, Rabbit Monoclonal, Rat Monoclonal, Humanized Monoclonal, Chimeric Monoclonal, Isotype Control Monoclonal
2) By Polyclonal Antibodies: Rabbit Polyclonal, Goat Polyclonal, Chicken Polyclonal, Donkey Polyclonal, Sheep Polyclonal, Serum Free Polyclonal
3) By Recombinant Antibodies: Recombinant Rabbit Monoclonal, Recombinant Mouse Monoclonal, Single Chain Variable Fragment, Fragment Antigen Binding, Multispecific Engineered Antibody, Recombinant Antibody Pair Capture And Detection
4) By Nanobodies: Single Domain Antibody Camelid, Single Domain Antibody Alpaca, Fluorescent Protein Fused Nanobody, Enzyme Conjugated Nanobody, Immobilized Nanobody For Affinity Purification, Intrabody Nanobody For Intracellular Detection
5) By Other Product Types: Secondary Antibodies Against Histidine Tag, Conjugated Secondary Antibodies Against Histidine Tag, Magnetic Beads Nickel Nitrilotriacetic Acid, Agarose Beads Nickel Nitrilotriacetic Acid, Enzyme Linked Immunosorbent Assay Kits For Histidine Tag, Lateral Flow Assays For Histidine Tag
Histidine Tag (His-Tag) Antibody Market Trends Redefining Industry Growth
Key players within the histidine tag (His-Tag) antibody market are concentrating on developing advanced offerings, such as automated biosensor-based His-tag quantification kits, with the goal of expediting and standardizing protein detection from both crude and purified samples. These automated biosensor-based His-tag quantification kits are defined as commercial assay systems that utilize biosensor technology to automatically identify and quantify His-tagged proteins. For instance, in November 2025, HexagonFab Limited (trading as Abselion), a UK-based life-science tools firm, unveiled its Tagged Protein Quantification Kit (His-tag) and Tagged Protein Sensor (His-tag Quantification). This solution is built for the Amperia platform and was developed using GenScript’s THE His Tag monoclonal antibodies. The automated biosensor-based His-tag quantification kit provides a fast, mix-and-read, antibody-free technique for directly quantifying His-tagged proteins in crude samples. When employed with Abselion’s Amperia biosensors, the system enables real-time, label-free analysis, streamlining the protein characterization workflow and eliminating the need for multiple, separate instruments. Its principal aim is to accelerate expression screening, optimize bioprocesses, and enhance quality control by delivering dependable His-tagged protein measurements without requiring specialized training.
Histidine Tag (His-Tag) Antibody Market Leading Companies: Who Holds The Strongest Market Presence?
Major companies operating in the histidine tag (his-tag) antibody market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories Inc., GeneTex Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Sino Biological Inc., Cell Signaling Technology Inc., Wuhan Elabscience Biotechnology Co. Ltd., ABclonal Technology Co. Ltd., Proteintech Group Inc., Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Diagnostics Inc., Aviva Systems Biology Corporation, Abnova Corporation, Boster Biological Technology Co. Ltd., Columbia Biosciences Corporation, NSJ Bioreagents
View The Full Histidine Tag (His-Tag) Antibody Market Report:
Histidine Tag (His-Tag) Antibody Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the histidine tag (His-Tag) antibody market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histidine tag (his-tag) antibody market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
